Versant Capital Management’s Chemours CC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $6.49K | Sell |
478
-154
| -24% | -$2.48K | ﹤0.01% | 2399 |
|
|
2026
Q2 | $13K | Buy |
632
+34
| +6% | +$778 | ﹤0.01% | 2143 |
|
|
2026
Q1 | $13.2K | Buy |
598
+413
| +223% | +$7.19K | ﹤0.01% | 2021 |
|
|
2025
Q4 | $2.18K | Sell |
185
-102
| -36% | -$1.31K | ﹤0.01% | 2442 |
|
|
2025
Q3 | $4.55K | Buy |
287
+119
| +71% | +$1.73K | ﹤0.01% | 2241 |
|
|
2025
Q2 | $1.92K | Buy |
+168
| New | +$1.89K | ﹤0.01% | 2391 |
|
|
2024
Q3 | – | Sell |
-13
| Closed | -$293 | – | 2022 |
|
|
2024
Q2 | $293 | Hold |
13
| – | – | ﹤0.01% | 1865 |
|
|
2024
Q1 | $341 | Hold |
13
| – | – | ﹤0.01% | 1766 |
|
|
2023
Q4 | $410 | Hold |
13
| – | – | ﹤0.01% | 1723 |
|
|
2023
Q3 | $365 | Hold |
13
| – | – | ﹤0.01% | 1752 |
|
|
2023
Q2 | $480 | Sell |
13
-19
| -59% | -$580 | ﹤0.01% | 1843 |
|
|
2023
Q1 | $958 | Buy |
32
+19
| +146% | +$626 | ﹤0.01% | 1452 |
|
|
2022
Q4 | $398 | Sell |
13
-100
| -88% | -$3K | ﹤0.01% | 1471 |
|
|
2022
Q3 | $3K | Hold |
113
| – | – | ﹤0.01% | 954 |
|
|
2022
Q2 | $4K | Hold |
113
| – | – | ﹤0.01% | 897 |
|
|
2022
Q1 | $4K | Hold |
113
| – | – | ﹤0.01% | 929 |
|
|
2021
Q4 | $4K | Hold |
113
| – | – | ﹤0.01% | 941 |
|
|
2021
Q3 | $3K | Hold |
113
| – | – | ﹤0.01% | 1019 |
|
|
2021
Q2 | $4K | Hold |
113
| – | – | ﹤0.01% | 953 |
|
|
2021
Q1 | $3K | Hold |
113
| – | – | ﹤0.01% | 1137 |
|
|
2020
Q4 | $2K | Sell |
113
-320
| -74% | -$7.61K | ﹤0.01% | 1096 |
|
|
2020
Q3 | $9K | Hold |
433
| – | – | ﹤0.01% | 687 |
|
|
2020
Q2 | $6K | Hold |
433
| – | – | ﹤0.01% | 773 |
|
|
2020
Q1 | $3K | Sell |
433
-17
| -4% | -$245 | ﹤0.01% | 899 |
|
|
2019
Q4 | $8K | Sell |
450
-19
| -4% | -$316 | ﹤0.01% | 762 |
|
|
2019
Q3 | $7K | Hold |
469
| – | – | ﹤0.01% | 828 |
|
|
2019
Q2 | $11K | Sell |
469
-501
| -52% | -$14.8K | 0.01% | 692 |
|
|
2019
Q1 | $36K | Hold |
970
| – | – | 0.02% | 366 |
|
|
2018
Q4 | $27K | Hold |
970
| – | – | 0.01% | 413 |
|
|
2018
Q3 | $38K | Sell |
970
-77
| -7% | -$3.37K | 0.02% | 376 |
|
|
2018
Q2 | $46K | Hold |
1,047
| – | – | 0.02% | 321 |
|
|
2018
Q1 | $50K | Sell |
1,047
-45
| -4% | -$2.25K | 0.02% | 289 |
|
|
2017
Q4 | $54K | Hold |
1,092
| – | – | 0.02% | 285 |
|
|
2017
Q3 | $55K | Sell |
1,092
-1,553
| -59% | -$73.3K | 0.03% | 238 |
|
|
2017
Q2 | $100K | Sell |
2,645
-2,895
| -52% | -$114K | 0.06% | 134 |
|
|
2017
Q1 | $213K | Sell |
5,540
-1,979
| -26% | -$59.6K | 0.12% | 74 |
|
|
2016
Q4 | $166K | Buy |
7,519
+1,060
| +16% | +$21.8K | 0.09% | 87 |
|
|
2016
Q3 | $103K | Buy |
6,459
+618
| +11% | +$7.06K | 0.06% | 129 |
|
|
2016
Q2 | $48K | Buy |
5,841
+92
| +2% | +$820 | 0.03% | 246 |
|
|
2016
Q1 | $40K | Buy |
5,749
+5,250
| +1,052% | +$26.4K | 0.02% | 285 |
|
|
2015
Q4 | $2K | Buy |
+499
| New | +$3.19K | ﹤0.01% | 1115 |
|
Other funds holding CC
Versant Capital Management's CC Position: Q3 2026 in Review
Versant Capital Management reduced its Chemours (CC) stake by 24% in Q3 2026, selling an estimated $2.48K and leaving 478 shares worth $6.49K. The position accounts for ﹤0.01% of the portfolio, ranked #2399.
Versant Capital Management first reported a position in CC in Q4 2015 and has held it in 41 quarters since. The position peaked at $213K in Q1 2017. 214 funds tracked by Wall St. Rank hold CC as of Q3 2026.
- Versant Capital Management held 478 shares of Chemours worth $6.49K as of Q3 2026.
- Versant Capital Management sold 154 Chemours shares in Q3 2026, an estimated $2.48K.
- Chemours made up ﹤0.01% of Versant Capital Management's portfolio in Q3 2026, its #2399 holding.
- Versant Capital Management first reported a position in Chemours in Q4 2015 and has held it in 41 quarters since.
- Versant Capital Management's Chemours position peaked at $213K in Q1 2017.
- 214 funds tracked by Wall St. Rank held Chemours as of Q3 2026.
Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.